Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New clinical results for Cypros' CPC-111

Feb. 28, 1997

Positive results reported for VasoCare in MI

Feb. 27, 1997

Harvard College discloses vascular injury-associated gene

Feb. 27, 1997

Cytel and Sumitomo expand agreement

Feb. 26, 1997

Bayer and Zeneca to comarket Ca antagonist

Feb. 26, 1997

Adenosine antagonists claimed by Fujisawa

Feb. 26, 1997

Unexpected phase I results reported for DuP-532

Feb. 25, 1997

Deltibant in SIRS

Feb. 21, 1997

Cylexin enters clinical trials in newborns

Feb. 21, 1997

Novel vasopressin antagonists from Fujisawa

Feb. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.